Structure and Dynamics of the EGF Receptor as Revealed by Experiments and Simulations and Its Relevance to Non-Small Cell Lung Cancer

• Published in: Cells (Basel, Switzerland) Switzerland), 2019-04, Vol.8 (4), p.316
• Main Authors: Martin-Fernandez, Marisa L, Clarke, David T, Roberts, Selene K, Zanetti-Domingues, Laura C, Gervasio, Francesco L
• Format: Article
• Language: English
• Subjects: Animals; Carcinoma, Non-Small-Cell Lung - metabolism; Cell growth; Disease resistance; Drug resistance; EGFR; Epidermal growth factor; Epidermal growth factor receptors; ErbB Receptors - chemistry; ErbB Receptors - metabolism; Glycosylation; Humans; Kinases; lung cancer; Lung Neoplasms - metabolism; MD simulations; Molecular Dynamics Simulation; Monomers; Mutation; Non-small cell lung carcinoma; Protein-tyrosine kinase receptors; receptor signaling; Review; Small cell lung carcinoma; Spectrum analysis; structure; Structure-Activity Relationship; Structure-function relationships
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells8040316

The epidermal growth factor receptor (EGFR) is historically the prototypical receptor tyrosine kinase, being the first cloned and the first where the importance of ligand-induced dimer activation was ascertained. However, many years of structure determination has shown that EGFR is not completely understood. One challenge is that the many structure fragments stored at the PDB only provide a partial view because full-length proteins are flexible entities and dynamics play a key role in their functionality. Another challenge is the shortage of high-resolution data on functionally important higher-order complexes. Still, the interest in the structure/function relationships of EGFR remains unabated because of the crucial role played by oncogenic EGFR mutants in driving non-small cell lung cancer (NSCLC). Despite targeted therapies against EGFR setting a milestone in the treatment of this disease, ubiquitous drug resistance inevitably emerges after one year or so of treatment. The magnitude of the challenge has inspired novel strategies. Among these, the combination of multi-disciplinary experiments and molecular dynamic (MD) simulations have been pivotal in revealing the basic nature of EGFR monomers, dimers and multimers, and the structure-function relationships that underpin the mechanisms by which EGFR dysregulation contributes to the onset of NSCLC and resistance to treatment.